A common Ile 823 Met variant of ATP-binding cassette transporter A1 gene (ABCA1) alters high density lipoprotein cholesterol level in Japanese population

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 105-112

  Harada, Tomohiro ^a   Imai, Yasushi ^a   Nojiri, Takefumi ^a   Morita, Hiroyuki ^a   Hayashi, Doubun ^a   Maemura, Koji ^a   Fukino, Keiko ^a   Kawanami, Daiji ^a   Nishimura, Go ^a   Tsushima, Kensuke ^a   Monzen, Koshiro ^a   Yamazaki, Tadashi ^a   Mitsuyama, Satoshi ^b   Shintani, Takahiko ^b   Watanabe, Narimasa ^b   Seto, Kumiko ^b   Sugiyama, Takao ^c   Nakamura, Fumitaka ^a   Ohno, Minoru ^a   Hirata, Yasunobu ^a   Yamazaki, Tsutomu ^a   Nagai, Ryozo ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b HITACHI LTD   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

ABC transporters; Association studies; Atherosclerosis; Genetics; Hyperlipidemia; Polymorphism

Indexed keywords

ABC TRANSPORTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EVALUATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0037630624     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00135-7     Document Type: Article

References (30)

1. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161:2002;1-16.
2. Oram J.F. The cholesterol mobilizing transport ABCA1 as a new therapeutic target for cardiovascular disease. Trends Cardiovasc. Med. 12:2002;170-175.
3. Tsimihodimos V., Karabina S.A., Tambaki A.P., Bairaktari E., Miltiadous G., Goudevenos J.A., Cariolou M.A., Chapman M.J., Tselepis A.D., Elisaf M. Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J. Lipid Res. 43:2002;256-263.
4. Mackness M.I., Arrol S., Abbott C., Durrington P.N. Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated with paraoxonase. Atherosclerosis. 104:1993;129-135.
5. Brook-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu K., Brewer C., Collins J.A., Molhuizen H.O., Loubster O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:1999;336-345.
6. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsh-Ozcurumerz M., Kaminski W.E., Hahmann H.W., Oette K., Roche G., Aslannidis C., Lakner K.J., Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:1999;347-351.
7. Rust S., Rosier M., Funke H., Real J., Amoura Z., Pietter J.C., Deleuze J.F., Brewer H.B., Duverger N., Denefle P., Assaman G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:1999;352-355.
8. Marcil M., Brooks-Wilson A., Clee S., Roomp K., Zhang L.H., Yu L., Collins J.A., van Dam M., Molhuizen H.O., Loubster O., Ouellette B.F., Sensen C.W., Fichter K., Mott S., Denis M., Boucher B., Pimstone S., Genest J. Jr, Kastelein J.J., Hayden M.R. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 354:1999;1341-1346.
9. Clifton-Bligh P., Nestel P.J., Whyte H.M. Tangier disease. Report of a case and studies of lipid metabolism. New Engl. J. Med. 286:1972;567-571.
10. McNeish J., Aiello R.J., Guyot D., Turi T., Gabel C., Aldinger C., Hoppe K.L., Roach M.L., Royer L.J., de Wet J., Broccardo C., Chimini G., Francone O.L. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA. 97:2000;4245-4250.
11. Orso E., Broccardo C., Kaminski W.E., Bottcher A., Liebisch G., Drobnik W., Gotz A., Chambenoit O., Diederich W., Langmann T., Spruss T., Luciani M.F., Rothe G., Lackner K.J., Chimini G., Schmitz G. Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat. Genet. 24:2000;192-196.
12. Cavelier L.B., Qiu Y., Bielicki J.K., Afzal V., Cheng J.F., Rubin E.M. Regulation and activity of the human ABCA1 gene in transgenic mice. J. Biol. Chem. 276:2001;18046-18051.
13. Iida A., Saito S., Sekine A., Kitamura Y., Kondo K., Mishima C., Osawa S., Harigae S., Nakamura Y. High-density single-nucleotide polymorphism (SNP) map of the 150-kb region corresponding to the human ATP-binding cassette transporter A1 (ABCA1) gene. J. Hum. Genet. 46:2001;522-528.
14. Lutucuta S., Ballantyne C.M., Elghannam H., Gotto A.M. Jr, Marian A.J. Novel polymorphism in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ. Res. 88:2001;969-973.
15. Brousseau M.E., Bodzioch M., Schaefer E.J., Goldkamp A.L., Kielar D., Probst M., Ordovas J.M., Aslanidis C., Lackner K.J., Rubins H.B., Collins D., Robins S.J., Wilson P.W.F., Schitz G. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low LDL cholesterol levels and coronary heart disease. Atherosclerosis. 154:2001;607-611.
16. Wang J., Burnett J.R., Near S., Young K., Zinman B., Hanley A.J.G., Connelly P.W., Harris S.B., Hegele R.A. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler. Thromb. Vasc. Biol. 20:2000;1983-1989.
17. Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y., Molhuizen H.O.F., Roomp K., Jukema W., van Wijland M., van Dam M., Hudson T.J., Brooks-Wilson A., Genest J. Jr, Kastelein J.J.P., Hayden M.R. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 103:2001;1198-1205.
18. Imai Y., Morita H., Kurihara H., Sugiyama T., Kato N., Ebihara A., Hamada C., Kurihara Y., Shindo T., Oh-hashi Y., Yazaki Y. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis. 49:2000;435-442.
19. Tanaka A.R., Ikeda Y., Abe-Dohmae S., Arakawa R., Sadanami K., Kidera A., Nakagawa S., Nagase T., Aoki R., Kioka N., Amachi T., Yokoyama S., Ueda K. Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjogren's syndrome. Biochem. Biophys. Res. Commun. 283:2001;1019-1025.
20. Huang W., Moriyama K., Koga T., Hua H., Ageta M., Kawabata M., Teramoto T., Sasaki J. Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease. Biochem. Biophys. Acta. 1537:2001;71-78.
21. Nishida Y., Hirano K., Tsukamoto K., Nagano M., Ikegami C., Roomp K., Ishihara M., Sakane N., Zhang Z., Tsujii Ki K., Matsuyama A., Ohama T., Matsuura F., Ishigami M., Sakai N., Hiraoka H., Hattori H., Wellington C., Yoshida Y., Misugi S., Hayden M.R., Egashira T., Yamashita S., Matsuzawa Y. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency. Biochem. Biophys. Res. Commun. 290:2002;713-721.
22. Morita H., Kurihara H., Imai Y., Sugiyama T., Hamada C., Sakai E., Mori M., Nagai R. Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. Thromb. Haemost. 85:2001;226-230.
23. Francone O.L., Royer L., Haghpassand M. Increased pre-β-HDL levels, cholesterol effulux, and LCAT mediated esterification in mice expressing the human chlesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgene. J. Lipid Res. 37:1996;1268-1277.
24. von Eckardstein A., Jauhiainen M., Huang Y., Metso J., Langer C., Pussinen P., Wu S., Ehnholm C., Assmann G. Phospholipid transfer protein mediated conversion of high density lipoprotein (HDL) generates generation of pre-β1-HDL. Biochem. Biophys. Acta. 1301:1996;255-261.
25. Barrans A., Collet X., Barbaras R., Jaspard B., Manent J., Vieu C., Chap H., Perret B. Hepatic lipase induces the formation of pre-β-1-high density lipoprotein (HDL) from triacylglycerol-rich-HDL. J. Biol. Chem. 269:1994;11572-11577.
26. Miida T., Kawano M., Fielding C.J., Fielding P.E. Regulation of the concentration of pre high density lipoprotein in normal plasma by cell membranes and lecitihin cholesterol acyltransferase. Biochemistry. 31:1992;11112-11120.
27. Acton S., Rigotti A., Landchulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
28. Rader D., Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin. Lipidol. 11:2000;141-148.
29. Moestrup S.K., Kozyraki R. Cubilin, a high density lipoprotein receptor. Curr. Opin. Lipidol. 11:2000;133-140.
30. Takagi S., Iwai N., miyazaki S., Nonogi H., Goto Y. Relationship between ABCA1 genetic variation and HDL cholesterol level in subjects with ischemic heart disease in Japanese. Thromb. Haemost. 88:2002;369-370.